Genetic Technologies hires new CFO


Wednesday, 11 June, 2014

Genetic Technologies (ASX:GTG) has appointed Eutillio Buccilli as its latest chief financial officer (CFO).

Buccilli has had more than 35 years of senior management experience in the financial services, contracting and recruitment, property and retail industries in both Australia and the USA.

He has previously worked at major companies including Coles Myer, General Electric and Challenger Limited. Through his career, he has accrued financial, corporate governance and commercial experience.

In March, GTG announced the results of a simulation study showing that its BREVAGen breast cancer risk assessment tool is a cost-effective way to direct tamoxifen chemoprevention. The company also entered another settlement and licensing deal as part of its US patent enforcement efforts.

Genetic Technologies (ASX:GTG) shares were trading unchanged at $0.04 as of around 1 pm on Wednesday.

Related News

Epilepsy disease model treated in a laboratory dish

A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...

Newborns have elevated levels of an Alzheimer's biomarker

What do the brains of newborns and patients with Alzheimer's disease have in common? Both...

Cannabis use may double risk of cardiovascular disease death

Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd